The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

Pfizer (PFE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the ...

Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped ...

Better still, if interest rates drop, as they're generally expected to over the coming year, the interest income you'll get ...

In September, the telecommunications giant announced it was boosting its dividend by 1.25 cents a share to $0.69 per share, ...